Kota Suzuki

1.2k total citations
45 papers, 776 citations indexed

About

Kota Suzuki is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kota Suzuki has authored 45 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kota Suzuki's work include Cardiovascular Function and Risk Factors (8 papers), Cardiomyopathy and Myosin Studies (5 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Kota Suzuki is often cited by papers focused on Cardiovascular Function and Risk Factors (8 papers), Cardiomyopathy and Myosin Studies (5 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Kota Suzuki collaborates with scholars based in Japan, United States and United Kingdom. Kota Suzuki's co-authors include Hiroaki Shimokawa, Satoshi Miyata, Kimio Satoh, Nobuhiro Kikuchi, Shohei Ikeda, Junichi Omura, Shinichiro Sunamura, Ryo Kurosawa, Taijyu Satoh and Masamichi Nogi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and SHILAP Revista de lepidopterología.

In The Last Decade

Kota Suzuki

42 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kota Suzuki Japan 17 285 265 166 148 84 45 776
Chen-Fuh Lam Taiwan 17 151 0.5× 238 0.9× 202 1.2× 204 1.4× 138 1.6× 30 829
Natthaphat Siri‐Angkul Thailand 14 193 0.7× 318 1.2× 126 0.8× 66 0.4× 68 0.8× 30 682
Jue Ye China 16 200 0.7× 238 0.9× 275 1.7× 101 0.7× 76 0.9× 31 728
Betty Pat United States 19 297 1.0× 358 1.4× 76 0.5× 164 1.1× 200 2.4× 39 1.2k
Masashi Namba Japan 14 310 1.1× 277 1.0× 113 0.7× 287 1.9× 89 1.1× 46 879
Yunlong Zhang China 17 236 0.8× 187 0.7× 70 0.4× 100 0.7× 90 1.1× 35 758
Tsukasa Shimauchi Japan 14 196 0.7× 235 0.9× 99 0.6× 87 0.6× 77 0.9× 38 554
Dajun Wang United States 11 392 1.4× 275 1.0× 79 0.5× 111 0.8× 61 0.7× 18 712
Haiyi Yu China 17 375 1.3× 442 1.7× 103 0.6× 134 0.9× 76 0.9× 52 986
Cathrine Husberg Norway 18 289 1.0× 340 1.3× 101 0.6× 105 0.7× 76 0.9× 23 852

Countries citing papers authored by Kota Suzuki

Since Specialization
Citations

This map shows the geographic impact of Kota Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kota Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kota Suzuki more than expected).

Fields of papers citing papers by Kota Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kota Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kota Suzuki. The network helps show where Kota Suzuki may publish in the future.

Co-authorship network of co-authors of Kota Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Kota Suzuki. A scholar is included among the top collaborators of Kota Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kota Suzuki. Kota Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kainuma, Satoshi, Katsuhiro Omae, Naonori Kawamoto, et al.. (2025). Long-term Outcomes After Surgical Aortic Valve Replacement in Patients ≤65 Years: Comparison of Age- and Sex-Matched Japanese General Population. Annals of Thoracic Surgery Short Reports. 3(2). 432–437.
2.
Kawamoto, Naonori, et al.. (2025). Straight Longitudinal Aortotomy for Aortic Valve Replacement Through Right Anterior Minithoracotomy. Annals of Thoracic Surgery Short Reports. 3(4). 1064–1066.
5.
Suzuki, Kota, Ashif Aminulloh Fathnan, Takashi Kondo, et al.. (2023). Inkjet printed intelligent reflecting surface for indoor applications. Electronics Letters. 59(23). 1 indexed citations
6.
Suzuki, Kota, et al.. (2023). Multiple p38/JNK mitogen-activated protein kinase (MAPK) signaling pathways mediate salt chemotaxis learning in C. elegans. G3 Genes Genomes Genetics. 13(9). 1 indexed citations
7.
Suzuki, Kota, Brian Claggett, Masatoshi Minamisawa, et al.. (2021). Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial. European Journal of Heart Failure. 23(12). 2085–2090. 7 indexed citations
8.
Suzuki, Kota, Brian Claggett, Masatoshi Minamisawa, et al.. (2020). LIVER FUNCTION AND PROGNOSIS, AND INFLUENCE OF SACUBITRIL/VALSARTAN IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION. Journal of the American College of Cardiology. 75(11). 800–800. 6 indexed citations
9.
Suzuki, Kota, Brian Claggett, Masatoshi Minamisawa, et al.. (2020). Liver Function and Prognosis, and Influence of Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction. European Journal of Heart Failure. 22(9). 1662–1671. 41 indexed citations
10.
Suzuki, Kota, Brian Claggett, Masatoshi Minamisawa, et al.. (2020). Pulse Pressure, Prognosis, and Influence of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction. Hypertension. 77(2). 546–556. 24 indexed citations
11.
Satoh, Taijyu, Kimio Satoh, Nobuhiro Yaoita, et al.. (2017). Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension. Circulation Research. 120(8). 1246–1262. 40 indexed citations
12.
Suzuki, Kota, et al.. (2016). Changes of brain monoamine levels and physiological indexes during heat acclimation in rats. Journal of Thermal Biology. 58. 15–22. 15 indexed citations
13.
Kudo, Shun, Kimio Satoh, Masamichi Nogi, et al.. (2016). SmgGDS as a Crucial Mediator of the Inhibitory Effects of Statins on Cardiac Hypertrophy and Fibrosis. Hypertension. 67(5). 878–889. 29 indexed citations
14.
Satoh, Kimio, Kota Suzuki, Shinichiro Sunamura, et al.. (2016). Novel Biomarkers for Cardiac Hypertrophy, Fibrosis and Failure: Cyclophilin A and Basigin—Clinical Application of Basic Research-. Journal of Cardiac Failure. 22(9). S159–S159. 2 indexed citations
15.
Omura, Junichi, Kimio Satoh, Nobuhiro Kikuchi, et al.. (2016). Protective Roles of Endothelial AMP-Activated Protein Kinase Against Hypoxia-Induced Pulmonary Hypertension in Mice. Circulation Research. 119(2). 197–209. 87 indexed citations
16.
Suzuki, Kota, et al.. (2015). Influence of circadian disruption on neurotransmitter levels, physiological indexes, and behaviour in rats. Chronobiology International. 32(10). 1449–1457. 29 indexed citations
17.
Ellawindy, Alia, Kimio Satoh, Shinichiro Sunamura, et al.. (2015). Rho-Kinase Inhibition During Early Cardiac Development Causes Arrhythmogenic Right Ventricular Cardiomyopathy in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 35(10). 2172–2184. 27 indexed citations
18.
Ikeda, Shohei, Kimio Satoh, Nobuhiro Kikuchi, et al.. (2014). Crucial Role of Rho-kinase in Pressure-overload-induced Right Ventricular Hypertrophy and Dysfunction in Mice. Journal of Cardiac Failure. 20(10). S144–S144. 2 indexed citations
19.
Sunakawa, Keisuke, Ichiro Tsukimoto, Yukiko Tsunematsu, et al.. (2012). Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children. Journal of Infection and Chemotherapy. 18(4). 456–465. 15 indexed citations
20.
Terakado, Nagaaki, Satoru Shintani, Mariko Mihara, et al.. (2000). Expression of Cu,Zn-SOD, Mn-SOD and GST-pi in oral cancer treated with preoperative radiation therapy.. Oncology Reports. 7(5). 1113–7. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026